We are live on ! Find out more
BCI

Bain Capital Investors Portfolio holdings

AUM $3.27B
1-Year Est. Return 3.23%
This Fund
S&P 500
This Quarter Est. Return
+66.14%
1 Year Est. Return
+3.23%
3 Year Est. Return
+87.05%
5 Year Est. Return
+97.69%
10 Year Est. Return
+813.76%
AUM
$4.61B
AUM Growth
+$1.49B
Cap. Flow
-$83.4M
Cap. Flow %
-1.81%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$157M

Top Sells

Rank Stock Value
1
SGRY icon
Surgery Partners
SGRY
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 99.77%
2 Communication Services 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERE
1
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$2.78B 60.39%
65,679,781
+5,480,052
+9% +$157M
SGRY icon
2
Surgery Partners
SGRY
$1.99B
$1.6B 34.65%
49,946,972
-8,301,277
-14% -$241M
AVAH icon
3
Aveanna Healthcare
AVAH
$1.99B
$219M 4.74%
81,600,880
– –
ADV icon
4
Advantage Solutions
ADV
$393M
$10.5M 0.23%
115,600
– –

Similar funds

AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return

Bain Capital Investors's Q4 2023 Portfolio in Review

As of Q4 2023, Bain Capital Investors held 4 positions worth $4.61B, up 48% from $3.12B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Bain Capital Investors opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Communication Services.

  • Bain Capital Investors added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023, an estimated $157M increase.
  • Bain Capital Investors's biggest Q4 2023 reduction was Surgery Partners, cutting an estimated $241M.
  • Bain Capital Investors's ten largest holdings make up 100% of its $4.61B portfolio in Q4 2023.
  • Bain Capital Investors opened 0 new positions and closed 0 in Q4 2023.
  • Bain Capital Investors's portfolio value rose 48% quarter-over-quarter to $4.61B.

Based on Bain Capital Investors's 13F filing for Q4 2023, filed 13 Feb 2024.